Article Information
PubMed
Print ISSN
Online ISSN
History
- Received March 9, 2021
- Accepted March 2, 2022
- Published online June 22, 2022.
Article Versions
- Earlier version (March 19, 2022 - 01:42).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2022 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Markus Walles,
- Michael Berna,
- Wenying Jian,
- Simon Hauri,
- Shawna Hengel,
- Lloyd King,
- John C. Tran,
- Cong Wei,
- Keyang Xu, and
- Xiaochun Zhu
- Pharmacokinetic Science, Novartis Institutes for Biomedical Research, Basel, Switzerland (M.W.); Biotechnology Discovery Research-ADME, Eli Lilly and Company, Indianapolis, Indiana (M.B.); Drug Metabolism and Pharmacokinetics, Janssen Research & Development, Spring House, Pennsylvania (W.J.); Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland (S.Ha.); Quantitative Pharmacology and Disposition, Seagen, Inc., Bothell, Washington (S.He.); Drug Metabolism and Pharmacokinetics, UCB Biopharma, Slough, UK (L.K.); Bioanalytical Sciences (K.X.) and Biochemical and Cellular Pharmacology (J.C.T.), Genentech, South San Francisco, California; Drug Metabolism and Pharmacokinetics, Biogen, Inc., Cambridge, Massachusetts (C.W.); and Drug Metabolism and Pharmacokinetics, Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts (X.Z.)
- Address correspondence to:
Dr. Markus Walles, Novartis Institutes for Biomedical Research/Pharmacokinetic Sciences, Fabrikstrasse 14 1.02.10, 4056 Basel, Switzerland. E-mail: markus.walles{at}novartis.com